GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | SLC51B | multiple interactions | EXP | | 6480464 | CTD | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC51B mRNA | PMID:27344345 | SLC51B | increases expression | ISO | Slc51b (Mus musculus) | 6480464 | CTD | 1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA | PMID:19407337 PMID:27853831 PMID:28549656 PMID:30352267 PMID:30517764 PMID:33749747 | SLC51B | multiple interactions | ISO | Slc51b (Mus musculus) | 6480464 | CTD | 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of SLC51B mRNA; [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of SLC51B mRNA; [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of SLC51B protein; Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA]; PPARA protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] | PMID:28549656 PMID:30352267 PMID:33749747 PMID:36787806 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |